Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance
Launched by AUBURN UNIVERSITY · Jul 29, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how curcumin, a substance found in turmeric, and EGCG, a compound in green tea, might help improve mood and a specific brain protein called BDNF (brain-derived neurotrophic factor) in adults aged 18 to 50 who are experiencing mood disturbances. The researchers want to find out if taking these supplements for eight weeks can help reduce feelings of sadness or anxiety and increase levels of BDNF in the blood. Participants will be randomly assigned to either receive the supplements or a placebo (which looks like the real thing but doesn't contain the active ingredients).
To join this study, you need to be between 18 and 50 years old and have a certain level of mood distress, as measured by a questionnaire. You'll also need to have been stable on any medications or supplements for the past three months and be able to read and speak English. However, if you are currently taking curcumin or green tea daily, are pregnant or nursing, or have specific hormonal disorders, you won’t be eligible. If you decide to participate, you can expect to take the supplements daily for two months and help researchers learn more about managing mood disturbances.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults age 18-50
- • Depression subscale score of \>9/21 on the DASS-21
- • No change in medications or supplements over the past 3 months
- • Can read and speak English
- Exclusion Criteria:
- • Currently consume curcumin or green tea daily
- • Currently, pregnant, nursing, or trying to become pregnant
- • Currently diagnosed with a perimenopausal disorder
About Auburn University
Auburn University is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a commitment to interdisciplinary collaboration, the university leverages its diverse expertise in health sciences, engineering, and social sciences to conduct rigorous research that addresses pressing healthcare challenges. Auburn University’s Clinical Trials Office ensures adherence to ethical standards and regulatory compliance, facilitating high-quality research that contributes to the scientific community and enhances patient care. Through its robust infrastructure and support services, Auburn University is poised to make significant contributions to clinical research and public health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Auburn, Alabama, United States
Patients applied
Trial Officials
Andrew D Fruge, PhD
Principal Investigator
Auburn University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported